Navigation Links
Vein Condition May Mask Serious Clot Disorder

Superficial vein thrombosis linked to deep vein thrombosis, study says

MONDAY, July 20 (HealthDay News) -- A supposedly harmless condition -- superficial vein thrombosis, or varicose veins that have become swollen and painful -- may herald the presence of a more dangerous problem.

One-quarter of patients with superficial vein thrombosis (SVT) in an Austrian study actually had deep vein thrombosis (DVT), a potentially life-threatening condition.

"The diagnosis of [SVT] has long been considered to be a benign entity which could be managed in the doctor's office [but] in fact may be the tip of the iceberg," said Dr. Robert Lookstein, an associate professor of radiology and surgery at the Mount Sinai School of Medicine in New York City.

"I think it's a good idea for anybody with [superficial vein thrombosis] to undergo routine ultrasound screening of the deep veins of their legs to exclude this very, very serious diagnosis," Lookstein continued.

This advice does not apply to individuals with "regular" varicose veins, only to those who are experiencing varicose veins that are "quite engorged and firm to the touch," Lookstein said.

Many doctors may already be on the alert.

"This [finding] does not surprise me," said Dr. Robert Rosen, director of vascular intervention at Lenox Hill Hospital in New York City. "They [the study authors] are documenting something that doctors are already doing."

SVT, explained Lookstein, happens when varicose veins in the calves or thighs become filled with blood clots. "They become painful, can become hot and patients can have low-grade fevers," he said. "It's a condition that can be quite uncomfortable."

Unlike SVT, which is visible on the surface of the skin, DVT is a blood clot that forms in veins deeper in the body. Complications can include pulmonary embolism, when a piece of the clot in the leg breaks off and travels to the lung; and post-thrombotic syndrome, in which the clots in the leg never heal, sometimes leading to loss of function of the legs, Lookstein said.

"This can transform somebody who would otherwise be a working member of the community and turn them into somebody unable to work, somebody who is bedbound," he said.

The authors of the new study, from the Medical University of Graz in Austria, looked at 46 patients (32 women and 14 men) who came to the dermatology department with SVT.

One-quarter of the patients had DVT, usually without symptoms. Of these, three-quarters had DVT in the same leg as the superficial vein thrombosis, 9 percent had DVT in the other leg and 18 percent had it in both legs, the researchers said.

Anybody with SVT should undergo routine screening with duplex ultrasound, which can be performed either in a doctor's office or by a vascular specialist, Lookstein said.

The findings were published in the July issue of the Archives of Dermatology.

More information

The U.S. National Heart, Lung, and Blood Institute has more on deep vein thrombosis.

SOURCES: Robert Rosen, M.D., director, vascular intervention, Lenox Hill Hospital, New York City; Robert Lookstein, M.D., associate professor, radiology and surgery, Mount Sinai School of Medicine, New York City; July 2009 Archives of Dermatology

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Worlds First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe
2. Health clinic conditions may be to blame for decrease in primary care physicians
3. Aging Institute May Die Before its Time, Due To Economic Conditions Yet Washington Based Non-Profit Organization Forges Ahead with Scheduled Landmark Conference
4. Helen Sher Launches Her Rosacea Awareness Campaign 2009 to Help Sufferers of this Distressing Condition
5. Kids With Eye Condition at Risk for Poor Mental Health
6. 63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likely
7. Omega-3 EPA: Treatment for a Heart Condition
8. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
9. Obesity and diabetes double risk of HF -- patients with both conditions very difficult to treat
10. Common migraine pain condition also prevalent in cluster headache
11. Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions
Post Your Comments:
(Date:10/13/2015)... Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... To incentivize would-be customers, eMarketing Concepts began a $1 promotion – effectively offering all ... a resounding success, and within weeks the company was flooded with phone calls from ...
(Date:10/13/2015)... ... , ... The Bill Howe Family of Companies is an award winning HVAC ... remediation services. Family-owned and operated for 35 years, they have maintained value, ethics and ... two years in a row from the Union Tribune Reader’s Poll, a Healthiest Company ...
(Date:10/12/2015)... ... 2015 , ... Heroes in Recovery (HIR) is proud to ... Network’s Moments of Change conference in West Palm Beach, Florida. Rob Waggener, CEO ... Dauphinais who exemplify the ideals of the Heroes in Recovery movement. , Noah ...
(Date:10/12/2015)... , ... October 12, 2015 , ... Kevin Costello, winner of the “Check-In and Win ... embarks today for his dream vacation to Hawaii. , “I didn’t believe I could win ... says. “This contest encouraged me to get to the gym and invest in my own ...
(Date:10/12/2015)... ... 12, 2015 , ... The American Society of Clinical Hypnosis ... education and clinical training in a health care discipline. , Many practitioners ... as: losing weight, managing pain, or stopping smoking, etc. Frequently, extravagant statements and ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... Therapy Catapult to advance development of large scale ... immunotherapy. Under the agreement, the Cell Therapy Catapult ... to support advanced clinical trials and eventual commercialization ... --> The Cell Therapy Catapult is a ...
(Date:10/12/2015)... WASHINGTON , Oct. 12, 2015  Former White House ... Press Secretary for the House Narcotics Committee, Robert Weiner ... "Rewriting Drug Policy." The two emphasize that this is now ... Clinton to Jeb Bush , Carly Fiorina ... Sordello cite the newest federal statistics, which they call "a ...
(Date:10/12/2015)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic, and the Dental sectors of healthcare, announced today ... 2015, its guidance for the fourth quarter of 2015, ... Senior Secured Credit Facility. --> ...
Breaking Medicine Technology: